Intra-Cellular Therapies Inc (ITCI)

89.31 +3.14 (+3.64%) USD  |  NASDAQ  |  Nov 05, 16:00
89.31 0.00 (0.00%) After-Hours: 16:02
More

Intra-Cellular Therapies Asset Impairment Charge (Quarterly)

Asset Impairment Charge (Quarterly) Chart

View Asset Impairment Charge (Quarterly) for ITCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Asset Impairment Charge (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Asset Impairment Charge Definition

Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.

Read full definition.

Asset Impairment Charge (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Asset Impairment Charge (Quarterly) Benchmarks

ACADIA Pharmaceuticals Inc --
Ionis Pharmaceuticals Inc --
Madrigal Pharmaceuticals Inc --
AbbVie Inc Upgrade
Arcus Biosciences Inc Upgrade